Sinovac

Sinovac Biotech Ltd. is a prominent China-based biopharmaceutical company concentrating on the comprehensive research, development, and production of vaccines. The company primarily develops inactivated vaccines, leveraging established technological approaches to create immunizations against a range of infectious diseases. Its core capabilities span the entire vaccine lifecycle, from initial laboratory research through clinical trials, manufacturing, and global distribution, aiming to address significant public health challenges.

The company was founded in 1999 by Yin Weidong, a medical professional whose earlier career included significant work investigating hepatitis in China during the 1980s. This foundational experience provided a deep understanding of infectious disease dynamics and the critical need for effective preventive measures. Weidong’s vision was to establish a biopharmaceutical entity dedicated to applying scientific innovation to create impactful public health solutions through vaccination.

Sinovac's vaccines are utilized globally by healthcare systems, governments, and international organizations to protect populations. The company's overarching mission is to supply vaccines that contribute to the elimination of human diseases worldwide. It remains forward-looking, continuously working towards broadening its vaccine portfolio and enhancing its capacity to deliver essential immunization solutions to improve global health outcomes.